Alexander's, Inc. (ALX)
$
225.19
+0.88 (0.39%)
Key metrics
Financial statements
Free cash flow per share
7.6567
Market cap
1.1 Billion
Price to sales ratio
5.0264
Debt to equity
0
Current ratio
0
Income quality
0.9914
Average inventory
0
ROE
0.2734
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Alexander's, Inc. is a real estate investment trust with a portfolio of seven properties located in the greater New York City metropolitan area. The company reported an income before tax of $43,444,000.00 showcasing its pre-tax profitability. Additionally, the company earned an interest income of $24,429,000.00 showcasing its financial investments. Reflecting the wear and tear of its assets, the company reported depreciation and amortization expenses of $37,897,000.00. The diluted EPS is $8.46 accounting for potential share dilution, while the net total of other income and expenses is -$38,389,000.00 reflecting non-core financial activities. This financial performance indicates a carefully managed portfolio that continues to focus on generating sustainable income. In the market landscape, the stock is priced at $225.19 positioning it in the higher-end market. Despite its attractive valuation, the stock has a low average trading volume of 19,334.00 indicating lower market activity. With a market capitalization of $1,150,110,635.00 the company is classified as a small-cap player, highlighting its potential for growth within the industry. It is a key player in the REIT - Retail industry, contributing significantly to the overall market landscape. Furthermore, it belongs to the Real Estate sector, driving innovation and growth. This combination of strategic positioning and financial performance underscores Alexander's, Inc.'s role in the real estate investment sector, appealing to investors looking for opportunities in a dynamic market.
Is Alexander's, Inc. (ALX) a good investment?
Investing in Alexander's, Inc. (ALX) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bullish outlook. Always conduct your own research before investing.
What is Alexander's, Inc. (ALX)'s stock forecast?
Analysts predict Alexander's, Inc. stock to fluctuate between $184.76 (low) and $251.63 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Alexander's, Inc.'s market capitalization?
As of 2025-05-30, Alexander's, Inc.'s market cap is $1,150,110,635, based on 5,107,290 outstanding shares.
How does Alexander's, Inc. compare to competitors like PROLOGIS, INC.?
Compared to PROLOGIS, INC., Alexander's, Inc. has a Lower Market-Cap, indicating a difference in performance.
Does Alexander's, Inc. pay dividends?
Alexander's, Inc. pays dividends. The current dividend yield is 8.30%, with a payout of $4.50 per share.
How can I buy Alexander's, Inc. (ALX) stock?
To buy Alexander's, Inc. (ALX) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ALX. Place an order (Market, Limit, etc.).
What is the best time to invest in Alexander's, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did Alexander's, Inc. perform in the last earnings report?
Revenue: $226,374,000 | EPS: $8.46 | Growth: -57.64%.
Where can I find Alexander's, Inc.'s investor relations reports?
Visit https://www.alx-inc.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Alexander's, Inc.?
You can explore historical data from here
What is the all-time high and low for Alexander's, Inc. stock?
All-time high: $308.39 (2021-03-15) | All-time low: $155.60 (2023-05-26).
What are the key trends affecting Alexander's, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
ALX, HMN and EBC made it to the Zacks Rank #1 (Strong Buy) income stocks list on June 2, 2025.
zacks.com
WTKWY and ALX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on June 2, 2025.
globenewswire.com
SOUTH SAN FRANCISCO, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced that management will participate in the Jefferies 2025 Global Healthcare Conference. Details are as follows:
zacks.com
ALX and WTKWY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 29, 2025.
zacks.com
ALX, ISNPY and EBC made it to the Zacks Rank #1 (Strong Buy) income stocks list on May 29, 2025.
zacks.com
Here is how Alexander's (ALX) and Berkeley Group Holdings PLC Unsponsored ADR (BKGFY) have performed compared to their sector so far this year.
globenewswire.com
SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced that it will host a webcast event on May 20, 2025, to provide an update on ALX2004, the Company's potentially best- and first-in-class investigational antibody-drug conjugate (ADC). The webcast will highlight the novel mechanism of action, preclinical data and clinical development strategy for ALX2004 following clearance of the Investigational New Drug application from the U.S. Food and Drug Administration earlier this year.
zacks.com
Alexander's (ALX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
seekingalpha.com
This neither the best of times nor the worst of times for REIT investors. This article presents a list of 10 REITs that would merit a Sell rating even in the best of times, given their current condition. All 10 REITs face significant risks due to revenue shrinkage, and most are struggling with heavy indebtedness and a high risk of dividend cuts.
globenewswire.com
PARAMUS, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that its Board of Directors has declared a regular quarterly dividend of $4.50 per share payable on May 30, 2025 to stockholders of record on May 12, 2025.
See all news
